Gagelmann N, Salit RB, Schroeder T, Chiusolo P, Finazzi MC, Gurnari C, Pagliuca S, Rautenberg C, Rubio MT, Maciejewski JP, Vannucchi A, Guglielmelli P, Nozzoli C, Leimkühler N, Angelucci E, Gambella M, Rambaldi A, Reinhardt HC, Bacigalupo A, Scott BL, Heidel FH, Popat U, Kröger N

Transplant Cell Ther. 2026 09 17;:

GVHD prophylaxis with PTCy, ATG, PTCy+ATG, or no in vivo T-cell depletion in RIC matched-donor PBSC transplantation for AML and MDS.

Coman T, Morisset S, Devillier R, D'Aveni M, Baron F, Bay JO, El-Cheikh J, Bilger K, Bulabois CE, Castilla-Llorente C, Ceballos P, Chalandon Y, Chantepie S, Joris M, Chevallier P, Alani M, Cornillon J, Daguindeau E, Forcade E, Mokeddem C, Guillerm G, Labussiere H, Lewalle P, Loschi M, Maertens J, Malard F, Malfuson JV, Maillard N, Mear JB, Nguyen-Quoc S, Pivert C, Poire X, Rubio MT, Suarez F, Turlure P, Villate A, Yakoub-Agha I, Raus N, Robin M, Huynh A, Michallet M

Bone Marrow Transplant. 2026 09 12;:

Response kinetics following CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry.

Manson G, Di Blasi R, Houot R, Morschhauser F, Cartron G, Gastinne T, Blaise D, Gros FX, Bories P, Le Bras F, Rubio MT, Mohty M, Bay JO, Guidez S, Castilla Llorente C, Jardin F, Durand A, Guffroy B, Loschi M, Drieu La Rochelle L, Abraham J, Chauchet A, Herbreteau L, Choquet S, Joris M, Carras S, Damaj GL, Decroocq J, Aline TS, Hermine O, Nicolas-Virelizier E, Gat E, Le Gouill S, Bachy E, Dulery R

Bone Marrow Transplant. 2026 08 21;:

Fludarabine combined with treosulfan or total body irradiation as a conditioning therapy before allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia. A retrospective matched-pair analysis from the ALWP of the EBMT.

Swoboda R, Labopin M, Kröger N, Stelljes M, Schroeder T, Dreger P, Bug G, McDonald A, Özçelik T, Rovira M, Blau IW, Kunadt D, Peffault de Latour R, Rabitsch W, Eder M, Rubio MT, Spyridonidis A, Peric Z, Giebel S, Mohty M, Ciceri F

Bone Marrow Transplant. 2026 07 8;:

ALLOPLUS: allogeneic hematopoietic stem cell transplantation in children and adult people living with human immunodeficiency virus, a retrospective study of the SFGM-TC.

Jondreville L, Nguyen S, Ceballos P, Forcade E, Devillier R, Xhaard A, Suarez F, Bilger K, Huynh A, Labussière-Wallet H, Beguin Y, Beckerich F, Turlure P, Chantepie S, Bulabois CE, Mear JB, Castilla-Llorente C, Mohty M, Robin M, Poiré X, Rubio MT, Berceanu A

Bone Marrow Transplant. 2026 07 6;:

The neurotoxic legacy of CAR-T cells: where do we stand?

Pagliuca S, Jacquet C, Rubio MT, Sorrentino P

Ther Adv Neurol Disord. 2026 05 15;19:17562864261440261

Outcomes and salvage strategies for large B-cell lymphoma progressing after second-line CAR T-cell therapy: A DESCAR-T study from the LYSA group.

Sesques P, Manson G, Cartron G, Gros FX, Morschhauser F, Castilla-Llorente C, Brisou G, Bories P, Thieblemont C, Drieu La Rochelle L, Tessoulin B, André A, Rossi C, Paillassa J, Guidez S, Capes A, Herbreteau L, Choquet S, Bay JO, Chauchet A, Lebras L, Claves F, Abraham J, Malfuson JV, Rubio MT, Decroocq J, Fornecker LM, Damaj G, Fouillet L, Joris M, Loschi M, Hermine O, Hafirassou H, Zele EV, Dupont V, Gouill SL, Houot R, Camus V

Hemasphere. 2026 05;10(5):e70356

Impact of stem cell source in HLA-matched hematopoietic stem cell transplant for acute lymphoblastic leukemia in first complete remission: a study from the GRAALL and the SFGM-TC.

Jestin M, Maury S, Huynh A, Forcade E, Srour M, Castilla-Llorente C, Mear JB, Chantepie S, Schneidawind D, Passweg J, Alani M, Bulabois CE, Cornillon J, Loschi M, Malfuson JV, Brissot E, Turlure P, Poiré X, Graux C, Raus N, Lhéritier V, Villate A, Daguindau E, Chalandon Y, Bilger K, Guillerm G, Bay JO, Loiseau C, Maillard N, Devillier R, Rubio MT, Paul F, François S, Chevallier P, Labussière-Wallet H, Dombret H, Nguyen S, Boissel N, Dhédin N

Bone Marrow Transplant. 2026 04 16;:

PTCy or ATG for Matched Transplantation in Myelofibrosis.

Chiusolo P, Bacigalupo A, Salit R, Schroeder T, Finazzi MC, Gurnari C, Pagliuca S, Metzdorf J, Rautenberg C, Robin M, Rubio MT, Maciejewski J, Popat U, Rambaldi A, Reinhardt HC, Scott B, Kröger N, Gagelmann N

Am J Hematol. 2026 02 23;:

A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the tran

Rampotas A, Aspa-Cilleruelo JM, Koster L, Avenoso D, Passweg J, Sala E, Robin M, Myhre AE, de Witte M, Nur E, Chevallier P, Schroeder T, Srour M, Chiusolo P, Salmenniemi U, Verbeek M, Finazzi MC, Castilla-Llorente C, Rubio MT, Sobieralski P, Sockel K, Alabdulkarim A, Drozd-Sokolowska J, Raj K, Battipaglia G, Czerw T, Polverelli N, Hernández-Boluda JC, McLornan DP

Bone Marrow Transplant. 2025 12 24;:

Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT.

Sobieralski P, Czerw T, Gras L, Koster L, Kröger N, Schroeder T, Friis L, Metafuni E, Passweg J, Robin M, Stelljes M, Broers AEC, Chevallier P, Zeiser R, Rubio MT, Verbeek M, Yonal-Hindilerden I, Pastore D, Zaucha J, Raj K, Drozd-Sokołowska J, Battipaglia G, Polverelli N, Hernández-Boluda JC, McLornan DP

Bone Marrow Transplant. 2025 10 15;:

Transplantation in lower risk MDS patients: a prospective phase 2 trial based on donor availability.

Sebert M, Thepot S, Cluzeau T, Duployez N, Lefebvre T, Chaffaut C, Orvain C, Loschi M, Peterlin P, Chevallier P, D'Aveni M, Rubio MT, Rauzy O, Huynh A, Charbonnier A, Sapena R, Chermat F, Ceballos P, Fossard G, Nguyen S, Park S, Adès L, Peffault De Latour R, Preudhomme C, Fenaux P, Chevret S, Robin M

Blood Adv. 2025 10 8;:

Thiotepa-busulfan-fludarabine compared to clofarabine-based conditioning for haploidentical transplant with posttransplant cyclophosphamide in patients with myeloid malignancies: a retrospective study from the SFGM-TC.

Jullien M, Brissot E, Daguindau E, Loschi M, Bazarbachi A, Labussiere-Wallet H, Huynh A, Schmidt-Tanguy A, Charbonnier A, Turlure P, Beckerich F, Devillier R, Bay JO, Srour M, Ceballos P, Alani M, Souchet L, Marchand T, Rubio MT, Forcade E, Cornillon J, Chantepie S, Bulabois CE, Villate A, Garnier A, Peterlin P, Le Bourgeois A, Guillaume T, Chevallier P,

Bone Marrow Transplant. 2025 09 15;:

Optimized GMP-grade Wharton's jelly's mesenchymal stromal cells manufacturing and administration protocol for Graft versus Host disease prevention.

Pochon C, Perouf R, Notarantonio AB, Bertrand A, Charif N, Marcelo CB, Fouquet G, Cauchois G, Bensoussan D, Moulin D, Pagliuca S, de Isla N, Sartelet H, D'Aveni M, Rubio MT

Curr Res Transl Med. 2025 09 10;73(4):103543

Genomic and immunogenomic profiling of extramedullary acute myeloid leukemia reveals actionable clonal branching and frequent immune editing.

Collignon C, Hansen T, Hercus C, Ruzinova MB, Roth Guepin G, Bonmati C, Rubio MT, Feugier P, Gaudfrin M, Sartelet H, Divoux M, Muller M, Heath S, Uy GL, Spencer DH, Chen DY, Pagliuca S, Ferraro F

Blood Cancer J. 2025 08 13;15(1):136

Oral decitabine and cedazuridine maintenance after haematopoietic stem-cell transplantation in very high-risk acute myeloid leukaemia or myelodysplastic syndrome (GFM-DACORAL-DLI): a multicentre, single-arm, phase 2 trial.

Robin M, D'Aveni M, Stamatoullas A, Raffoux E, Chevallier P, Garnier A, Mediavilla C, Carre M, Himberlin C, Sébert M, Ravinet A, Desseaux K, Labussière H, Alani M, Rubio MT, Huynh A, Adès L, de Latour RP, Paul F, Chermat F, Petit R, Mokeddem C, Charbonnier A, Thépot S, Chevret S, Fenaux P,

Lancet Haematol. 2025 08 7;:

Overall Survival After Allogeneic Transplantation in Advanced Cutaneous T-Cell Lymphomas (CUTALLO): A Propensity Score-Matched Controlled Prospective Study.

de Masson A, Beylot-Barry M, Ram-Wolff C, Mear JB, Dalle S, Rouanet J, Ingen-Housz-Oro S, Orvain C, Abraham J, Dereure O, Charbonnier A, Cornillon J, Longvert C, Barete S, Boulinguez S, Wierzbicka-Hainaut E, Aubin F, Rubio MT, Bernard M, Schmidt-Tanguy A, Houot R, Pham-Ledard A, Michonneau D, Labussière-Wallet H, Bouaziz JD, Grange F, Moins-Teisserenc H, Jondeau K, Mourah S, Battistella M, Daguindau E, Loschi M, Picard A, Franck N, Maillard N, Huynh A, Nguyen S, Marçais A, Chaby G, Ceballos P, Le Corre Y, Maury S, Bay JO, Adamski H, Bachy E, Forcade E, Socié G, Bagot M, Chevret S, Peffault de Latour R,

J Clin Oncol. 2025 06 13;:JCO2500183

Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study From the Société Francophone de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC).

Chalandon Y, Devillier R, Boumendil A, Nguyen S, Bulabois CE, Ceballos P, Brissot E, Rubio MT, Labussière-Wallet H, Maertens J, Chevallier P, Maillard N, Poiré X, Castilla-Llorente C, Beguin Y, Cornillon J, Maury S, Marchand T, Daguindau E, Bay JO, Turlure P, Joris M, Menard AL, Bilger K, Guillerm G, François S, Bazarbachi A, Chantepie S, Lewalle P, Marçais A, Loschi M, Benakli M, Chauvet P, Forcade E, Huynh A, Robin M, Masouridi-Levrat S

Am J Hematol. 2025 05 6;:

Autologous stem cell transplantation for adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. A study by the Acute Leukemia Working Party of the EBMT.

Swoboda R, Labopin M, Giebel S, Maertens J, Parovichnikova E, Versluis J, Pavlu J, Kopinska A, Capria S, Raida L, Rambaldi A, Caillot D, Folber F, Nachbaur D, Ozturk M, Aljurf M, Rubio MT, Gorin NC, Lanza F, Nagler A, Mohty M, Ciceri F

BMC Cancer. 2025 04 28;25(1):787

Ruxolitinib stopped before transplantation does not induce cytokine release in myelofibrosis.

Villar S, Curis E, Schlageter MH, Bosselut N, Charbonnier A, Rubio MT, Turlure P, Labussière H, Bay JO, Cornillon J, Vincent L, Orvain C, Kiladjian JJ, Michonneau D, Socié G, Robin M

Cancer Immunol Immunother. 2025 04 24;74(6):181

A phase II study of ponatinib for prevention of relapse after allotransplantation in internal tandem duplication mutation positive (FLT3-ITD+) acute myeloid leukemia: the PONALLO trial.

Chevallier P, Thiebaut A, François S, Chantepie S, Rubio MT, Labussiere-Wallet H, Brissot E, Maillard N, Huynh A, Coiteux V, Jullien M, Garnier A, Le Bourgeois A, Peterlin P, Guillaume T

Haematologica. 2025 04 17;:

The landscape of immune monitoring in CAR-T cell therapy: A comprehensive review and survey study by the Cellular Therapy and Immunobiology Working Party of the EBMT.

Pagliuca S, Malard F, Mooyaart JE, Daskalakis M, Gabellier L, Yakoub-Agha I, Ram R, Besley C, Forcade E, Vucinic V, Corral LL, Vydra J, von Tresckow B, Amat P, Amrolia P, Vandenberghe P, Stölzel F, Sica S, Rubio MT, Hoogenboom JD, Ortiz-Maldonado V, Nagler A, Kuball J, Chabannon C, Ruggeri A

Blood Rev. 2025 02 15;:101272

Differential Clinical and Immunological Impacts of Anti-T-Lymphocyte Globulin (ATLG) vs. Anti-Thymocyte Globulin (ATG) in Preventing Graft-Versus-Host Disease Post-Allogeneic Hematopoietic Stem Cell Transplantation: A Comparative Study.

Notarantonio AB, Morisset S, Piucco R, Pérès M, Boulangé L, Alitcher A, Brouard J, Monchablon L, Campidelli A, El Ouahabi S, Guisnel C, Moulin C, Kicki C, Roth-Guepin G, Feugier P, Bittencourt MC, Aarnink A, D'Aveni-Piney M, Hergalant S, Pagliuca S, Rubio MT

Am J Hematol. 2025 02 4;:

Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma treated with anti-CD19 CAR-T cells: CARTHYM, a study from the French national DESCAR-T registry.

Galtier J, Mesguich C, Sesques P, Dupont V, Bachy E, Di Blasi R, Thieblemont C, Gastinne T, Cartron G, Brisou G, Gros FX, Decroocq J, Morschhauser F, Rubio MT, Drieu La Rochelle L, Le Bras F, Carras S, Chauchet A, Bay JO, Joris M, Loschi M, Tanguy-Schmidt A, Marquet A, Camus V, Le Gouill S, Houot R, Bouabdallah K

Hemasphere. 2025 02;9(2):e70091

Role of molecular alterations in transplantation decisions for patients with primary myelofibrosis.

Luque Paz D, Gagelmann N, Benajiba L, Riou J, Salit RB, Orvain C, Schroeder T, Bories C, Gurnari C, Badbaran A, Boyer-Perrard F, Pagliuca S, Rautenberg C, Tavitian S, Panagiota V, Ianotto JC, Thol FR, Cayssials E, Heuser M, Rubio MT, Cassinat B, Daltro de Oliveira R, Sauter CS, Maciejewski JP, Reinhardt HC, Scott BL, Ugo V, Kröger N, Kiladjian JJ, Robin M

Blood Adv. 2024 11 19;:

Severe ICANS after CAR T-cell therapy and assessment of prevention with levetiracetam for seizure prophylaxis following CAR T-cell for DLBCL & PMBCL in Europe: a survey on behalf of the Cellular Therapy & Immunobiology Working Party (CTIWP) of the EBMT.

Angelillo P, Alarcon Tomas A, Campodonico E, Novak U, Gabellier L, Blau IW, Kwon M, Ram R, Forcade E, Besley C, Vucinic V, Kröger N, Corral LL, Vydra J, Ferrari S, von Tresckow B, Rubio MT, Hernani R, Sica S, Stölzel F, Rovira M, Wagner-Drouet E, Pérez-Simón JA, Castilla-Llorente C, Ferreri AJM, Hoogenboom JD, Sanchez Ortega I, Malard F, Kuball J, Ruggeri A

Bone Marrow Transplant. 2024 10 25;:

Autologous stem cell transplantation in T-cell/histiocyte-rich large B-cell lymphoma: EBMT Lymphoma Working Party study.

Renders S, Ngoya M, Finel H, Rubio MT, Townsend WM, Schroers R, Novak U, Schaap N, Aljurf M, Helbig G, Collin M, Kobbe G, Anne H, Pérez-Simón JAA, Bloor A, Ghesquieres H, Sureda A, Schmitz N, Glass B, Dreger P

Blood Adv. 2024 08 30;:

Novel prognostic scoring systems for severe CRS and ICANS after anti-CD19 CAR T cells in large B-cell lymphoma.

Sesques P, Kirkwood AA, Kwon M, Rejeski K, Jain MD, Di Blasi R, Brisou G, Gros FX, le Bras F, Bories P, Choquet S, Rubio MT, Iacoboni G, O'Reilly M, Casasnovas RO, Bay JO, Mohty M, Joris M, Abraham J, Castilla Llorente C, Loschi M, Carras S, Chauchet A, La Rochelle LD, Hermine O, Guidez S, Cony-Makhoul P, Fogarty P, Le Gouill S, Morschhauser F, Gastinne T, Cartron G, Subklewe M, Locke FL, Sanderson R, Barba P, Houot R, Bachy E

J Hematol Oncol. 2024 08 6;17(1):61

Adenovirus infections after allogeneic hematopoietic cell transplantation in children and adults: a study from the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.

Styczynski J, Tridello G, Knelange N, Wendel L, Ljungman P, Mikulska M, Gil L, Cesaro S, Averbuch D, von dem Borne P, Xhaard A, Mielke S, Neven B, Snowden JA, Dalle JH, Rubio MT, Crawley C, Maertens J, Kuball J, Chevallier P, Michel G, Gabriel M, Burns D, Wynn RF, Renard C, Blijlevens N, Jubert C, Gedde-Dahl T, Collin M, Labussiere-Wallet H, Kalwak K, Broers AEC, Yakoub-Agha I, Itäla-Remes M, de la Camara R

Bone Marrow Transplant. 2024 07 10;:

Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registry.

Herbaux C, Bret C, Bachy E, Bories P, Di Blasi R, Cuffel A, Gastinne T, Lamy T, Roussel M, Bouabdallah K, Beauvais D, Cartron G, Bay JO, Blaise D, Rubio MT, Mohty M, Le Bras F, Casasnovas O, Guy J, Guidez S, Llorente CC, Hermine O, La Rochelle LD, Carras S, Guffroy B, Caillat-Zucman S, Houot R, Le Gouill S

Haematologica. 2024 06 20;:

PD-1 blockade and allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma, a matter of time: a national study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.

Kaphan E, Bettega F, Vallet N, Fegueux N, Robin M, Bazarbachi A, Nguyen S, Beauvais D, Forcade E, De Oca MCM, Devillier R, Chevallier P, Loschi M, Huynh A, Bay JO, Rubio MT, Suarez F, Francois S, Poire X, Contentin N, Desmier D, Charbonnier A, Cornillon J, Chantepie S, Turlure P, Bulabois CE, Michonneau D, Villate A,

Haematologica. 2024 06 13;:

Anti-T-lymphocyte globulin improves GvHD-free and relapse-free survival in myelofibrosis after matched related or unrelated donor transplantation.

Rathje K, Gagelmann N, Salit RB, Schroeder T, Gurnari C, Pagliuca S, Panagiota V, Rautenberg C, Cassinat B, Thol F, Robin M, Oechsler S, Heuser M, Rubio MT, Maciejewski JP, Reinhardt HC, Scott BL, Kröger N

Bone Marrow Transplant. 2024 05 21;:

Highly immunosuppressive myeloid cells correlate with early relapse after allogeneic stem cell transplantation.

Notarantonio AB, Bertrand A, Piucco R, Fievet G, Sartelet H, Boulangé L, de Isla N, De Carvalho Bittencourt M, Hergalant S, Rubio MT, D'Aveni M

Exp Hematol Oncol. 2024 05 11;13(1):50

Treatment Patterns and Clinical Outcomes of Patients with Moderate to Severe Acute Graft-Versus-Host Disease: A Multicenter Chart Review Study.

Michonneau D, Devillier R, Keränen M, Rubio MT, Nicklasson M, Labussière-Wallet H, Carre M, Huynh A, Viayna E, Roset M, Finzi J, Pfeiffer M, Thunström D, Lara N, Sabatelli L, Chevallier P, Itälä-Remes M

Hematol Rep. 2024 05 6;16(2):283-294

Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.

Villar S, Chevret S, Poire X, Joris M, Chevallier P, Bourhis JH, Forcade E, Chantepie S, Beauvais D, Raus N, Bay JO, Loschi M, Devillier R, Duléry R, Ceballos P, Rubio MT, Servais S, Nguyen S, Robin M

Bone Marrow Transplant. 2024 03 21;:

IDALLO study: A retrospective multicenter study of the SFGM-TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1-mutated AML after allogeneic hematopoietic cell transplantation.

Caillet A, Simonet-Boissard M, Forcade E, Robin M, Rubio MT, Couturier MA, Srour M, Maillard N, Devillier R, Huynh A, Bourhis JH, Simand C, Chantepie S, Boisson C, Kroemer M, Deconinck E, Berceanu A

Hemasphere. 2024 03;8(3):e44

Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, mu

Brissot E, Labopin M, Labussière H, Fossard G, Chevallier P, Guillaume T, Yakoub-Agha I, Srour M, Bulabois CE, Huynh A, Chantepie S, Menard AL, Rubio MT, Ceballos P, Dulery R, Furst S, Malard F, Blaise D, Mohty M

Blood Cancer J. 2024 02 19;14(1):31

Splenic irradiation for myelofibrosis prior to hematopoietic cell transplantation: A global collaborative analysis.

Gagelmann N, Hobbs GS, Campodonico E, Helbig G, Novak P, Schroeder T, Schneider A, Rautenberg C, Reinhardt HC, Bosques L, Heuser M, Panagiota V, Thol F, Gurnari C, Maciejewski JP, Ciceri F, Rathje K, Robin M, Pagliuca S, Rubio MT, Rocha V, Funke V, Hamerschlak N, Salit R, Scott BL, Duarte F, Mitrus I, Czerw T, Greco R, Kröger N

Am J Hematol. 2024 02 15;:

Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry.

Lacan C, Lambert J, Forcade E, Robin M, Chevallier P, Loron S, Bulabois CÉ, Orvain C, Ceballos P, Daguindau E, Charbonnier A, Chalandon Y, Bernard M, Simand C, Rubio MT, Turlure P, Maertens J, Huynh A, Loschi M, Bay JO, Guillerm G, Alani M, Castilla-Llorente C, Poiré X, Chantepie S, Maillard N, Beguin Y, Marçais A, Cornillon J, Malfuson JV, Maury S, Meuleman N, Villate A, Bekadja MA, Walter-Petrich A, Jacque N, Srour M, Devillier R, Nguyen S

J Hematol Oncol. 2024 01 7;17(1):2

Transfusion needs after CAR T-cell therapy for large B-cell lymphoma: predictive factors and outcome. A DESCAR-T study.

Vic S, Thibert JB, Bachy E, Cartron G, Gastinne T, Morschhauser F, Le Bras F, Bouabdallah K, Despas F, Bay JO, Rubio MT, Mohty M, Casasnovas O, Choquet S, Castilla-Llorente C, Guidez S, Loschi M, Guffroy B, Carras S, Drieu La Rochelle L, Guillet M, Houot R

Blood Adv. 2024 01 4;:

Comparison of two reduced intensity conditioning regimens: Flu-Bu2 versus RIC-TBF in allogeneic hematopoietic stem cell transplantation.

Verstraete E, Baumann C, Rousseau H, Campidelli A, Rubio MT, D'Aveni M

Leuk Lymphoma. 2023 11 21;:1-4

A new sequential conditioning regimen based on CPX- 351/Vyxeos ("Vyx-Seq") in patients with higher risk myelodysplastic syndromes.

Notarantonio AB, Roth-Guépin G, Bonmati C, Divoux M, Kicki C, Pagliuca S, Campidelli A, Rubio MT, D'Aveni-Piney M

Leuk Res. 2023 10 16;135:107405

Non-Relapse Mortality after CAR T-Cell therapy for Large B-Cell Lymphoma: A LYSA Study from the DESCAR-T Registry.

Lemoine J, Bachy E, Cartron G, Beauvais D, Gastinne T, Di Blasi R, Rubio MT, Guidez S, Mohty M, Casasnovas O, Joris M, Castilla-Llorente C, Haioun C, Hermine O, Loschi M, Carras S, Bories P, Fradon T, Herbaux C, Sesques P, Le Gouill S, Morschhauser F, Thieblemont C, Houot R

Blood Adv. 2023 09 6;:

Use of letermovir in umbilical cord blood transplantation based on risk scores.

Rivera Franco MM, Rafii H, Volt F, Kenzey C, Cappelli B, Scigliuolo GM, Rocha V, Raus N, Dalle JH, Chevallier P, Robin M, Rubio MT, Ruggeri A, Gluckman E

Blood Adv. 2023 08 22;7(16):4315-4318

Systemic complement activation influences outcomes after allogeneic hematopoietic cell transplantation: A prospective French multicenter trial.

Notarantonio AB, D'aveni-Piney M, Pagliuca S, Ashraf Y, Galimard JE, Xhaard A, Marçais A, Suarez F, Brissot E, Feugier P, Urien S, Bouazza N, Jacquelin S, Meatchi T, Bruneval P, Frémeaux-Bacchi V, Peffault De Latour R, Hermine O, Durey-Dragon MA, Rubio MT

Am J Hematol. 2023 07 22;:

The Prospective Effects of Coping Strategies on Mental Health and Resilience at Five Months after HSCT.

Corman M, Dambrun M, Rubio MT, Cabrespine A, Brindel I, Bay JO, Peffault de La Tour R

Healthcare (Basel). 2023 07 7;11(13):

Autologous hematopoietic cell transplantation (autoHCT) for T-cell/histiocyte-rich large B-cell lymphoma (THRLBCL): An EBMT Lymphoma Working Party study

Renders S, Finel H, Ngoya M, Boumendil A, Schaap N, Ghesquieres H, Bloor A, Pérez-Simón JA, Huynh A, Kobbe G, Collin M, Busca A, Helbig G, Aljurf M, Daskalakis M, Schroers R, Carpenter B, Rubio MT, Peniket A, Sureda A, Schmitz N, Glass B, Dreger P

Hematol Oncol. 2023 06;41 Suppl 2:447

Prognostic factors for cellular therapies - CART and allogeneic SCT - in relapsed /refractory large B cell lymphoma (LBCL)

Glass B, Sureda A, Boumendil A, Dreger P, Corradini P, Ram R, Kroeger N, Castagna L, Pabst T, Kwon M, Wulf G, García-Sancho AM, Solano C, Stelljes M, Reinhardt HC, Rubio MT, Malladi R, Blaise D, Besley C, Forcade E, von Bonin M, Struessmann T, Hilgendorf I, Martínez-López J, Perez-Simon JA, Bethge W, Schmitz N

Hematol Oncol. 2023 06;41 Suppl 2:449-451

Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation.

Pagliuca S, Gurnari C, Hercus C, Hergalant S, Hong S, Dhuyser A, D'Aveni M, Aarnink A, Rubio MT, Feugier P, Ferraro F, Carraway HE, Sobecks R, Hamilton BK, Majhail NS, Visconte V, Maciejewski JP

Nat Commun. 2023 05 31;14(1):3153

Age-related immune cell dynamics influence outcomes after allogeneic haematopoietic cell transplantation.

Jandin A, Pochon C, Campidelli A, D'Aveni M, Kicki C, Notarantonio AB, Roth Guepin G, Mbuyi TA, Feugier P, Chastagner P, Schweitzer C, de Carvalho Bittencourt M, Rubio MT, Pagliuca S

Br J Haematol. 2023 04 24;:

Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study.

de Masson A, Beylot-Barry M, Ram-Wolff C, Mear JB, Dalle S, d'Incan M, Ingen-Housz-Oro S, Orvain C, Abraham J, Dereure O, Charbonnier A, Cornillon J, Longvert C, Barete S, Boulinguez S, Wierzbicka-Hainaut E, Aubin F, Rubio MT, Bernard M, Schmidt-Tanguy A, Houot R, Pham-Ledard A, Michonneau D, Brice P, Labussière-Wallet H, Bouaziz JD, Grange F, Moins-Teisserenc H, Jondeau K, Michel L, Mourah S, Battistella M, Daguindau E, Loschi M, Picard A, Franck N, Maillard N, Huynh A, Nguyen S, Marçais A, Chaby G, Ceballos P, Le Corre Y, Maury S, Bay JO, Adamski H, Bachy E, Forcade E, Socié G, Bagot M, Chevret S, Peffault de Latour R, ,,

Lancet. 2023 04 24;:

A French single-center experience on allogeneic stem cell transplant cryopreservation during severe acute respiratory syndrome coronavirus 2 pandemic.

Laroye C, Thilly N, Gauthier M, Luc A, Latger-Cannard V, Eschwege V, Bensoussan D, Pochon C, Campidelli A, Rubio MT, D'Aveni M, Decot V

Cytotherapy. 2023 04 17;:

Matched related versus unrelated versus haploidentical donors for allogeneic transplantation in AML patients achieving first complete remission after two induction courses: a study from the ALWP/EBMT.

Nagler A, Labopin M, Mielke S, Passweg J, Blaise D, Gedde-Dahl T, Cornelissen JJ, Salmenniemi U, Yakoub-Agha I, Reményi P, Socié G, van Gorkom G, Labussière-Wallet H, Huang XJ, Rubio MT, Byrne J, Craddock C, Griškevičius L, Ciceri F, Mohty M

Bone Marrow Transplant. 2023 04 12;:

Efficacy of haematopoietic stem cell boost as a rescue for poor graft function after haematopoietic stem cell transplantation: A multicentre retrospective study on behalf of the Francophone Society for Bone Marrow Transplantation and Cell Therapy (SFGM-TC

Gaffet M, Wiedemann A, Dalle JH, Bilger K, Forcade E, Robin M, Cornillon J, Labussière-Wallet H, Ceballos P, Bulabois CE, Loschi M, Orvain C, Rubio MT, Neven B, Pagliuca S, Pochon C

Br J Haematol. 2023 03 27;:

Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation.

Gagelmann N, Badbaran A, Salit RB, Schroeder T, Gurnari C, Pagliuca S, Panagiota V, Rautenberg C, Cassinat B, Thol FR, Wolschke C, Robin M, Heuser M, Rubio MT, Maciejewski JP, Reinhardt HC, Scott BL, Kröger N

Blood. 2023 03 20;:

A 16-month-long experience of COVID-19 in allogeneic haematopoietic stem cell transplantation recipients: An SFGM-TC multicentre cohort study.

Xhaard A, Xhaard C, Rubio MT, Berceanu A, Botella-Garcia C, Coman T, Tavernier E, Labussière-Wallet H, Chevallier P, Legrand F, Thiebaut A, Menard AL, Paillard C, Chantepie S, Robin M, Nguyen S

Br J Haematol. 2023 03 15;:

Comparison of NK alloreactivity prediction models based on KIR-MHC interactions in haematopoeitic stem cell transplantation.

Dhuyser A, Remen T, Pérès M, Chamberlain-Evans V, Nemat-Gorgani N, Campidelli A, Clément S, Rubio MT, Trowsdale J, Aarnink A, Traherne J

Front Immunol. 2023 03 2;14:1028162

Late relapse after hematopoietic stem cell transplantation for acute leukemia: a retrospective study by SFGM-TC.

Kaphan E, Bettega F, Forcade E, Labussière-Wallet H, Fegueux N, Robin M, De Latour RP, Huynh A, Lapierre L, Berceanu A, Marcais A, Debureaux PE, Vanlangendonck N, Bulabois CE, Magro L, Daniel A, Galtier J, Lioure B, Chevallier P, Antier C, Loschi M, Guillerm G, Mear JB, Chantepie S, Cornillon J, Rey G, Poire X, Bazarbachi A, Rubio MT, Contentin N, Orvain C, Dulery R, Bay JO, Croizier C, Beguin Y, Charbonnier A, Skrzypczak C, Desmier D, Villate A, Carré M, Thiebaut-Bertrand A

Transplant Cell Ther. 2023 02 25;:

Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS.

Michel C, Robin M, Morisset S, Blaise D, Maertens J, Chevalier P, Castilla-Llorente C, Forcade E, Ceballos P, Yakoug-Agha I, Poire X, Carre M, Bay JO, Beguin Y, Loschi M, Huynh A, Guillerm G, François S, Mear JB, Duléry R, Suarez F, Bilger K, Cornillon J, Chalandon Y, Maillard N, Labussière-Wallet H, Charbonnier A, Turlure P, Berceanu A, Chantepie S, Maury S, Bazarbachi A, Menard AL, Nguyen-Quoc S, Rubio MT, D'Aveni M

Bone Marrow Transplant. 2023 02 11;:

Outcome prediction in myelodysplastic neoplasm undergoing hematopoietic cell transplant in the molecular era of IPSS-M.

Gurnari C, Gagelmann N, Badbaran A, Awada H, Dima D, Pagliuca S, D'Aveni-Piney M, Attardi E, Voso MT, Cerretti R, Wolschke C, Rubio MT, Maciejewski JP, Kröger N

Leukemia. 2023 01 28;:

Comorbidities in recipients of low transplant conditioning intensity regimens for acute myeloid leukemia: an ALWP EBMT study.

Fein JA, Shouval R, Galimard JE, Labopin M, Socié G, Finke J, Cornelissen JJ, Malladi R, Itälä-Remes M, Chevallier P, Orchard K, Bunjes D, Aljurf M, Rubio MT, Versluis J, Mohty M, Nagler A

Blood Adv. 2023 01 9;:

On behalf of the SFGM-TC: prophylactic donor lymphocyte infusion in patients treated with allogeneic stem-cell transplantation for high-risk myelodysplastic syndrome and acute myeloid leukemia.

Guisnel C, Schirmer L, Morisset S, Robin M, Labussière-Wallet H, Duléry R, Ceballos P, Forcade E, Nguyen S, Poiré X, Maertens J, Chantepie S, Chevallier P, Daguindau E, Villate A, Charbonnier A, Castilla-Llorente C, Contentin N, Huynh A, Yakoub-Agha I, Bulabois CE, Rubio MT, D'Aveni M

Acta Haematol. 2023 01 5;:

Does F-FDG PET/CT add value to conventional imaging in clinical assessment of chronic disseminated candidiasis?

Rammaert B, Maunoury C, Rabeony T, Correas JM, Elie C, Alfandari S, Berger P, Rubio MT, Braun T, Bakouboula P, Candon S, Montravers F, Lortholary O

Front Med (Lausanne). 2022 12 20;9:1026067

Comprehensive Transcriptomic Analysis of VISTA in Acute Myeloid Leukemia: Insights into Its Prognostic Value.

Pagliuca S, Gurnari C, Zhang K, Kewan T, Bahaj W, Mori M, Nautiyal I, Rubio MT, Ferraro F, Maciejewski JP, Wang L, Visconte V

Int J Mol Sci. 2022 11 28;23(23):

Pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) prevents severe SARS-CoV-2 infection in recipients of allogeneic hematopoietic stem cell transplantation during the Omicron wave: a multicentric retrospective study of SFGM-TC.

Jondreville L, D'Aveni M, Labussière-Wallet H, Le Bourgeois A, Villate A, Berceanu A, Bezsera SM, Thiebaut A, Boissard-Simonet M, Legrand M, Cornillon J, Rubio MT, Chevallier P, Nguyen S

J Hematol Oncol. 2022 11 28;15(1):169

Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe.

Rafii H, Ruggeri A, Kenzey C, Sanz J, Peffault de Latour R, Esquirol A, Michel G, Chevallier P, Rubio MT, Cornelissen JJ, Michallet M, Volt F, Rivera Franco MM, Scigliuolo GM, Cappelli B, Rocha V, Gluckman E

Blood Adv. 2022 11 9;:

Filling the Gap: The Immune Therapeutic Armamentarium for Relapsed/Refractory Hodgkin Lymphoma.

Hazane Leroyer E, Ziegler C, Moulin C, Campidelli A, Jacquet C, Rubio MT, Feugier P, Pagliuca S

J Clin Med. 2022 11 6;11(21):

Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: a study of the SFGM-TC.

Chauvet P, Paviglianiti A, Labopin M, Labussière H, Boissel N, Robin M, Maillard N, Ouachée-Chardin M, Forcade E, Poiré X, Chantepie S, Huynh A, Bulabois CE, Leclerc M, Maury S, Chevallier P, Cluzeau T, Mear JB, Cornillon J, Bilger K, Simand C, Beguin Y, Rubio MT, Yakoub-Agha I, Brissot E

Bone Marrow Transplant. 2022 10 19;:

Salvage haploidentical or cord-blood allogeneic stem cell transplantation after a prior alternative allograft in hematologic malignancies: a retrospective study from the SFGM-TC.

Cavalieri D, Rubio MT, Corriger A, Pereira B, Cabrespine A, Robin M, Labussière-Wallet H, Calleja A, Forcade E, Chevallier P, Guillerm G, Berceanu A, Bulabois CE, Maillard N, Nguyen S, Raus N, Schoemans H, Bay JO, Ravinet A

Eur J Haematol. 2022 09 24;:

A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma.

Bachy E, Le Gouill S, Di Blasi R, Sesques P, Manson G, Cartron G, Beauvais D, Roulin L, Gros FX, Rubio MT, Bories P, Bay JO, Llorente CC, Choquet S, Casasnovas RO, Mohty M, Guidez S, Joris M, Loschi M, Carras S, Abraham J, Chauchet A, Drieu La Rochelle L, Deau-Fischer B, Hermine O, Gastinne T, Tudesq JJ, Gat E, Broussais F, Thieblemont C, Houot R, Morschhauser F

Nat Med. 2022 09 22;:

Individual HLA heterogeneity and its implications for cellular immune evasion in cancer and beyond.

Pagliuca S, Gurnari C, Rubio MT, Visconte V, Lenz TL

Front Immunol. 2022 09 5;13:944872

Autologous stem cell transplantation (ASCT) for acute myeloid leukemia in patients in first complete remission after one versus two induction courses: A study from the ALWP of the EBMT.

Nagler A, Galimard JE, Labopin M, Blaise D, Arcese W, Trisolini SM, Wu D, Pigneux A, Van Gorkom G, Rubio MT, Gedde-Dahl T, Huynh A, Lanza F, Gorin NC, Mohty M

Cancer Med. 2022 07 26;:

Neuropilin-1 cooperates with PD-1 in CD8 T cells predicting outcomes in melanoma patients treated with anti-PD1.

Rossignol J, Belaid Z, Fouquet G, Guillem F, Rignault R, Milpied P, Renand A, Coman T, D'Aveni M, Dussiot M, Colin E, Levy J, Carvalho C, Goudin N, Cagnard N, Côté F, Babdor J, Bhukhai K, Polivka L, Bigorgne AE, Halse H, Marabelle A, Mouraud S, Lepelletier Y, Maciel TT, Rubio MT, Heron D, Robert C, Girault I, Lebeherec D, Scoazec JY, Moura I, Condon L, Weimershaus M, Pages F, Davoust J, Gross D, Hermine O

iScience. 2022 06 17;25(6):104353

Allogeneic stem cell transplantation-A curative treatment for paroxysmal nocturnal hemoglobinuria with PIGT mutation: A case report.

Schenone L, Notarantonio AB, Latger-Cannard V, Fremeaux-Bacchi V, De Carvalho-Bittencourt M, Rubio MT, Muller M, D'Aveni M

World J Clin Cases. 2022 06 16;10(17):5702-5707

PET-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T-cells.

Galtier J, Vercellino L, Chartier L, Olivier P, Tabouret-Viaud C, Mesguich C, Di Blasi R, Durand A, Raffy L, Gros FX, Madelaine I, Meignin V, Mebarki M, Rubio MT, Feugier P, Casasnovas O, Meignan M, Thieblemont C

Haematologica. 2022 06 9;:

Effective Letermovir Prophylaxis of CMV infection post allogeneic hematopoietic cell transplantation: Results from the French temporary authorization of use compassionate program.

Beauvais D, Robin C, Thiebaut A, Alain S, Coiteux V, Ducastelle-Lepretre S, Marçais A, Ceballos P, Xhaard A, Redjoul R, Nguyen S, Brissot E, Joris M, Turlure P, Rubio MT, Chevallier P, Bénard N, Liautard C, Yakoub-Agha I

J Clin Virol. 2022 Feb 15;148:105106

Wharton's jelly-derived stromal cells and their cell therapy applications in allogeneic haematopoietic stem cell transplantation.

Pochon C, Notarantonio AB, Laroye C, Reppel L, Bensoussan D, Bertrand A, Rubio MT, D'Aveni M

J Cell Mol Med. 2022 Jan 28;:

Measurable residual disease, FLT3-ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1-mutated acute myeloid leukemia.

Al Hamed R, Labopin M, Daguindau E, Niittyvuopio R, Huynh A, Socié G, Srour M, Henri Bourhis J, Kröger N, Tholouli E, Choi G, Poiré X, Martin H, Rubio MT, Jindra P, Blaise D, Beelen D, Labussière-Wallet H, Nagler A, Bazarbachi A, Mohty M

Cancer Med. 2022 Jan 20;:

CAR-T Cells Microscopic and Phenotypic Identification in the Peripheral Blood.

Lesesve JF, Cravat M, Boulangé L, Rubio MT, De Carvalho M

Mediterr J Hematol Infect Dis. 2022 ;14(1):e2022024

KIR in Allogeneic Hematopoietic Stem Cell Transplantation: Need for a Unified Paradigm for Donor Selection.

Dhuyser A, Aarnink A, Pérès M, Jayaraman J, Nemat-Gorgani N, Rubio MT, Trowsdale J, Traherne J

Front Immunol. 2022 ;13:821533

Outcomes of refractory or relapsed Hodgkin lymphoma patients with post autologous stem cell transplantation brentuximab vedotin maintenance : a French multicenter observational cohort study.

Marouf A, Cottereau AS, Kanoun S, Deschamps P, Meignan M, Franchi P, Sibon D, Antoine C, Gastinne T, Borel C, Hammoud M, Sicard G, Gille R, Cavalieri D, Stamatoullas A, Filliatre-Clement L, Lazarovici J, Chauchet A, Fornecker LM, Amorin S, Rocquet M, Raus N, Burroni B, Rubio MT, Bouscary D, Quittet P, Casasnovas RO, Brice P, Ghesquieres H, Tamburini J, Deau B

Haematologica. 2021 Dec 30;:

CAR-T cell therapy in primary central nervous system lymphoma (PCNSL): the clinical experience of the French LOC network.

Alcantara M, Houillier C, Blonski M, Rubio MT, Willems L, Waultier Rascalou A, Le Garff-Tavernier M, Maloum K, Bravetti CM, Souchet L, Roos-Weil D, Morel V, Uzunov M, Metz C, Dhib-Charfi M, Nguyen S, Shor N, Psimaras D, Weiss N, Jacque N, Solorzano S, Gauthier N, Le Cann M, Norol F, Soussain C, Choquet S

Blood. 2021 Dec 6;:

Impact of donor-derived CD34 + infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT.

Czerw T, Iacobelli S, Malpassuti V, Koster L, Kröger N, Robin M, Maertens J, Chevallier P, Watz E, Poiré X, Snowden JA, Kuball J, Kinsella F, Blaise D, Reményi P, Mear JB, Cammenga J, Rubio MT, Maury S, Daguindau E, Finnegan D, Hayden P, Hernández-Boluda JC, McLornan D, Yakoub-Agha I

Bone Marrow Transplant. 2021 Dec 1;:

Impact of COVID-19 pandemic on the use and release of cord blood units facilitated by the French Cord Blood Banks Network: on behalf of the Agency of Biomedicine, Eurocord and the French Society of Bone Marrow Transplant and Cell Therapy (SFGM-TC).

Rafii H, Ionescu I, Ruggeri A, Garnier F, Ballot C, Bensoussan D, Chabannon C, Dazey B, De Vos J, Gautier E, Giraud C, Larghero J, Cras A, Mialou V, Persoons V, Pouthier F, Thibert JB, Dalle JH, Michel G, Sinayoko M, Kenzey C, Volt F, Rocha V, Bay JO, Rubio MT, Robin M, Faucher C, Marry E, Gluckman E

Bone Marrow Transplant. 2021 Oct 7;:

[Mechanisms of resistance and escape to CAR-T cells].

Grinda T, Brouard J, Tran D, Rubio MT

Bull Cancer. 2021 Oct;108(10S):S128-S140

Improved outcome in children compared to adolescents and young adults after allogeneic hematopoietic stem cell transplant for acute myeloid leukemia: a retrospective study from the Francophone Society of Bone Marrow Transplantation and Cell Therapy (SFGM-

Pochon C, Detrait M, Dalle JH, Michel G, Dhédin N, Chalandon Y, Brissot E, Forcade E, Sirvent A, Izzadifar-Legrand F, Michallet M, Renard C, Yakoub-Agha I, Gonzales F, Bay JO, Kanold J, Cornillon J, Bulabois CE, Angoso M, Nguyen S, Balza M, Chevallier P, Rialland F, Bazarbachi A, Beguin Y, Huynh A, Ménard AL, Schneider P, Neven B, Paillard C, Raus N, Albuisson E, Remen T, Rubio MT

J Cancer Res Clin Oncol. 2021 Sep 4;:

Allogeneic hematopoietic stem cell transplantation from unmanipulated haploidentical donor and unrelated cord blood for T-cell lymphoma: a retrospective study from the Société Francophone de Greffe de Moelle et de Therapie Cellulaire.

Cornillon J, Daguenet E, Tournilhac O, Blaise D, NGuyen S, Wallet HL, Chevallier P, Dulery R, Forcade E, Srour M, Bazarbachi A, Contentin N, Lioure B, Tinquaut F, Bulabois CE, Rubio MT, Robin M, Bay JO

Bone Marrow Transplant. 2021 Aug 6;:

On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell Transplantation.

Campidelli A, Robin M, Remen T, Luc A, Labussière-Wallet H, Dulery R, Srour M, Ceballos P, Forcade E, Nguyen-Quoc S, Furst S, Turlure P, Bay JO, Simand C, Marçais A, Daguindau E, Rubio MT, D'Aveni M

Clin Lymphoma Myeloma Leuk. 2021 Jul 31;:

[Immunomonitoring of patients treated with CAR-T cells for hematological malignancy: Guidelines from the CARTi group and the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

Rubio MT, Varlet P, Allain V, Ballot C, Cuffel A, Deschamps M, Ferrand C, Foguenne J, Forcade E, Huynh A, Guihot A, Latouche JB, Lemarie C, Martinroche G, Morin F, Nguyen S, Schmit K, Servais S, Simonetta F, Yakoub-Agha I, Caillat Zucman S

Bull Cancer. 2021 Jul 9;:

Pulmonary alveolar proteinosis after allogeneic hematopoietic stem cell transplantation in adults: a French SFGM-TC survey.

Salvator H, Tcherakian C, Maillard N, Milin S, Bergeron A, Bondeelle L, Meignin V, NGuyen S, Souchet L, Guenounou S, Evrard SM, Rubio MT, Robin M, Sestili S, Brissot E, Fajac A, Catherinot E, Givel C, Chabrol A, Goyard C, Longchampt E, Chabi-Charvillat ML, Bernaudin JF, Couderc LJ

Chest. 2021 Jun 5;:

Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT.

Kröger N, Sbianchi G, Sirait T, Wolschke C, Beelen D, Passweg J, Robin M, Vrhovac R, Helbig G, Sockel K, Conneally E, Rubio MT, Beguin Y, Finke J, Bernasconi P, Morozova E, Clausen J, von dem Borne P, Schaap N, Schroyens W, Patriarca F, Di Renzo N, Yeğin ZA, Hayden P, McLornan D, Yakoub-Agha I

Leukemia. 2021 May 22;:

Umbilical cord blood transplants facilitated by the French cord blood banks network. On behalf of the Agency of Biomedicine, Eurocord and the French society of bone marrow transplant and cell therapy (SFGM-TC).

Rafii H, Garnier F, Ruggeri A, Ionescu I, Ballot C, Bensoussan D, Chabannon C, Dazey B, De Vos J, Gautier E, Giraud C, Larghero J, Cras A, Mialou V, Persoons V, Pouthier F, Thibert JB, Dalle JH, Michel G, Kenzey C, Volt F, Rocha V, Bay JO, Rubio MT, Faucher C, Marry E, Gluckman E

Bone Marrow Transplant. 2021 May 14;:

Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM-TC) multicentre cohort study.

Xhaard A, Xhaard C, D'Aveni M, Salvator H, Chabi ML, Berceanu A, Coman T, Beguin Y, Chalandon Y, Poiré X, Loschi M, Paillard C, Bruno B, Ceballos P, Dalle JH, Bilger K, Bay JO, Robin M, N'Guyen-Quoc S, Rubio MT

Br J Haematol. 2021 Feb 1;:

Thiotepa-busulfan-fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT.

Battipaglia G, Mauff K, Wendel L, Angelucci E, Mohty M, Arcese W, Santarone S, Rubio MT, Kroger N, Fox ML, Blaise D, Iori AP, Fanin R, Chalandon Y, Pioltelli P, Marotta G, Chiusolo P, Sever M, Solano C, Contentin N, de Wreede LC, Czerw T, Hernandez-Boluda JC, Hayden P, McLornan D, Yakoub-Agha I

Bone Marrow Transplant. 2021 Feb 1;:

Mental health and quality of life of patients undergoing hematopoietic stem cell transplantation (HSCT) prior to hospitalization: a cross-sectional complete state health study.

Corman M, Rubio MT, Cabrespine A, Brindel I, Bay JO, Peffault De La Tour R, Dambrun M

Health Psychol Behav Med. 2021 Jan 28;9(1):70-83

Retrospective and prospective measures of post-traumatic growth reflect different processes: longitudinal evidence of greater decline than growth following a hematopoietic stem-cell transplantation.

Corman M, Rubio MT, Cabrespine A, Brindel I, Bay JO, De La Tour RP, Dambrun M

BMC Psychiatry. 2021 Jan 11;21(1):27

[Eligibility of patients for CAR T-cell: Expert opinion-based collaborative work by the SFGM-TC].

Beauvais D, Bachy E, Baruchel A, Bay JO, Caillot D, Cartron G, Damaj G, Furst S, Le Gouill S, Morschhauser F, Rabian F, Rubio MT, Thieblemont C, Yakoub-Agha I

Bull Cancer. 2021 Jan 7;:

Scoring system for clinically significant CMV infection in seropositive recipients following allogenic hematopoietic cell transplant: an SFGM-TC study.

Beauvais D, Drumez E, Blaise D, Peffault de Latour R, Forcade E, Ceballos P, Uyttebroeck A, Labussière H, Nguyen S, Bourhis JH, Chevallier P, Thiebaut A, Poiré X, Maury S, Deconinck E, Cluzeau T, Brissot E, Huynh A, Rubio MT, Duhamel A, Yakoub-Agha I

Bone Marrow Transplant. 2020 Dec 18;:

Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma.

Vercellino L, Di Blasi R, Kanoun S, Tessoulin B, Rossi C, D'Aveni-Piney M, Obéric L, Bodet-Milin C, Bories P, Olivier P, Lafon I, Berriolo-Riedinger A, Galli E, Bernard S, Rubio MT, Bossard C, Meignin V, Merlet P, Feugier P, Le Gouill S, Ysebaert L, Casasnovas O, Meignan M, Chevret S, Thieblemont C

Blood Adv. 2020 Nov 24;4(22):5607-5615

Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: a French nationwide study.

Bossard JB, Beuscart JB, Robin M, Mohty M, Barraco F, Chevallier P, Marchand T, Rubio MT, Charbonnier A, Blaise D, Bay JO, Botella-Garcia C, Damaj G, Beckerich F, Ceballos P, Cluzeau T, Cornillon J, Meunier M, Orvain C, Duhamel A, Garnier F, Kiladjian JJ, Yakoub-Agha I,

Am J Hematol. 2020 Oct 27;:

Impact Of Spleen Size And Splenectomy On Outcomes Of Allogeneic Haematopoietic Cell Transplantation For Myelofibrosis: A Retrospective Analysis By The Chronic Malignancies Working Party On Behalf Of Ebmt.

Polverelli N, Mauff K, Kröger N, Robin M, Beelen D, Beauvais D, Chevallier P, Mohty M, Passweg J, Rubio MT, Maertens J, Finke J, Bornhäuser M, Vrhovac R, Helbig G, Mear JB, Castagna L, Reményi P, Angelucci E, Karakasis D, Rifòn J, Sirait T, Russo D, de Wreede L, Czerw T, Hernández-Boluda JC, Hayden P, McLornan D, Yakoub-Agha I

Am J Hematol. 2020 Oct 16;:

Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape.

Zalmaï L, Viailly PJ, Biichle S, Cheok M, Soret L, Angelot-Delettre F, Petrella T, Collonge-Rame MA, Seilles E, Geffroy S, Deconinck E, Daguindau E, Bouyer S, Dindinaud E, Baunin V, Le Garff-Tavernier M, Roos-Weil D, Wagner-Ballon O, Salaun V, Feuillard J, Brun S, Drenou B, Mayeur-Rousse C, Okamba P, Dorvaux V, Tichionni M, Rose J, Rubio MT, Jacob MC, Raggueneau V, Preudhomme C, Saas P, Ferrand C, Adotevi O, Roumier C, Jardin F, Garnache-Ottou F, Renosi F

Haematologica. 2020 Oct 13;Online ahead of print:

Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TC

Le Bourgeois A, Labopin M, Marçais A, de Latour RP, Blaise D, Chantepie S, N'Guyen S, Maillard N, Forcade E, Yakoub-Agha I, Huynh A, Marchand T, Bilger K, Ceballos P, Charbonnier A, Turlure P, Rubio MT, Béné MC, Guillaume T, Mohty M, Chevallier P,

Ann. Hematol.. 2020 Jun 20;:

Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Mamez AC, Dupont A, Blaise D, Chevallier P, Forcade E, Ceballos P, Mohty M, Suarez F, Beguin Y, Peffault De Latour R, Rubio MT, Tournilhac O, Nguyen S

J Hematol Oncol. 2020 May 19;13(1):56

[Awareness on the law of bioethics].

Bay JO, Dalle JH, Dulery R, Magro L, Nguyen-Quoc S, Robin M, Rubio MT, Huynh A

Bull Cancer. 2020 Apr 30;:

[CAR-T cell development and other gene therapy: Everything is not so easy].

Dalle JH, Baudoux E, Caillat-Zucman S, Colledani F, Pereira M, Bruno B, Nguyen S, Robin M, Rubio MT, Bay JO

Bull Cancer. 2020 Apr;107(4):408-409

Rabbit ATG/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel.

Bonifazi F, Rubio MT, Bacigalupo A, Boelens JJ, Finke J, Greinix H, Mohty M, Nagler A, Passweg J, Rambaldi A, Socie G, Solano C, Walker I, Barosi G, Kröger N

Bone Marrow Transplant.. 2020 Jan 22;:

Mobilized Multipotent Hematopoietic Progenitors Promote Expansion and Survival of Allogeneic Tregs and Protect Against Graft Versus Host Disease.

D'Aveni M, Notarantonio AB, Agbogan VA, Bertrand A, Fouquet G, Gastineau P, Garfa-Traoré M, De Carvalho M, Hermine O, Rubio MT, Zavala F

Front Immunol. 2020 ;11:607180

Mobilized Multipotent Hematopoietic Progenitors Stabilize and Expand Regulatory T Cells to Protect Against Autoimmune Encephalomyelitis.

Korniotis S, D'Aveni M, Hergalant S, Letscher H, Tejerina E, Gastineau P, Agbogan VA, Gras C, Fouquet G, Rossignol J, Chèvre JC, Cagnard N, Rubio MT, Hermine O, Zavala F

Front Immunol. 2020 ;11:607175

Myeloid-Derived Suppressor Cells in the Context of Allogeneic Hematopoietic Stem Cell Transplantation.

D'Aveni M, Notarantonio AB, Bertrand A, Boulangé L, Pochon C, Rubio MT

Front Immunol. 2020 ;11:989

Romiplostim in Patients undergoing Hematopoietic Stem Cell Transplantation: Results of a Phase I/II multicenter Trial.

Peffault de Latour R, Chevret S, Ruggeri AL, Suarez F, Souchet L, Michonneau D, Sicre de Fontbrune F, Coman T, Dhedin N, Rubio MT, Nguyen S, Mohty M, Socié G

Blood. 2019 Dec 5;:

Thiotepa and antithymocyte globulin-based conditioning prior to haploidentical transplantation with posttransplant cyclophosphamide in high-risk hematological malignancies.

Peric Z, Mohty R, Bastos J, Brissot E, Battipaglia G, Belhocine R, Sestili S, Giannotti F, Vekhoff A, Ledraa T, Legrand O, Lapusan S, Isnard F, Labopin M, Bonnin A, Mediavilla C, Rubio MT, Ruggeri A, Duléry R, Malard F, Mohty M

Bone Marrow Transplant.. 2019 Oct 31;:

Allogeneic stem cell transplantation in therapy-related myelodysplasia after autologous transplantation for lymphoma: a retrospective study of the SFGM-TC.

Jaimes-Albornoz D, Mannone L, Nguyen-Quoc S, Chalandon Y, Chevallier P, Mohty M, Meunier M, Robin M, Ledoux MP, Guillerm G, Bay JO, Poiré X, Maillard N, Leclerc M, Daguindau E, Beguin Y, Rubio MT, Gyan E

Biol. Blood Marrow Transplant.. 2019 Jul 18;:

Outcomes of Salvage Haploidentical Transplant with Post-transplant Cyclophosphamide for Rescuing Graft Failure Patients: a Report on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.

Prata PH, Resche-Rigon M, Blaise D, Socié G, Rohrlich PS, Milpied N, Turlure P, Nguyen S, Sirvent A, Bulabois CE, Berceanu A, Charbonnier A, Chevallier P, Bay JO, Neven B, Jubert C, Mohty M, Rubio MT, de Latour RP

Biol. Blood Marrow Transplant.. 2019 May 23;:

Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome.

Guillaume T, Malard F, Magro L, Labopin M, Tabrizi R, Borel C, Chevallier P, Vigouroux S, Peterlin P, Garnier A, Rubio MT, Huynh A, Milpied N, Moreau P, Gaugler B, Yakoub-Agha I, Mohty M

Bone Marrow Transplant.. 2019 May 14;:

Thiotepa, busulfan and fludarabine conditioning regimen in T-cell replete HLA-haploidentical hematopoietic stem cell transplantation.

Duléry R, Bastos J, Paviglianiti A, Malard F, Brissot E, Battipaglia G, Médiavilla C, Giannotti F, Banet A, de Wyngaert ZV, Ledraa T, Belhocine R, Sestili S, Adaeva R, Lapusan S, Isnard F, Legrand O, Vekhoff A, Rubio MT, Ruggeri A, Mohty M

Biol. Blood Marrow Transplant.. 2019 Mar 11;:

Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematological malignancies carrying multidrug-resistance bacteria.

Battipaglia G, Malard F, Rubio MT, Ruggeri A, Mamez AC, Brissot E, Giannotti F, Dulery R, Joly AC, Baylatry MT, Kossman MJ, Tankovic J, Beaugerie L, Sokol H, Mohty M

Haematologica. 2019 Feb 7;:

Autologous haematopoietic stem cell transplantation (AHSCT) in autoimmune disease adult patients in France: analysis of the long-term outcome from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).

Guillaume-Jugnot P, Badoglio M, Labopin M, Terriou L, Yakoub-Agha I, Martin T, Lioure B, Marjanovic Z, Blaise D, Nguyen S, Pugnet G, Huynh A, Deligny C, Seinturier C, Garban F, Swiader L, Bay JO, Braun T, de Latour RP, Rubio MT, Farge D

Clin. Rheumatol.. 2019 Jan 21;:

Biologie, concepts et principes des CAR-T cells

Rubio MT, Galaine J, Borg C, Daguindau É

Bull Cancer. 2018 Dec;105 Suppl 2:S135-S146

Clofarabine/busulfan-based reduced intensity conditioning regimens provides very good survivals in acute myeloid leukemia patients in complete remission at transplant: a retrospective study on behalf of the SFGM-TC.

Bourgeois AL, Labopin M, Leclerc M, de Latour RP, Bourhis JH, Ceballos P, Orvain C, Wallet HL, Bilger K, Blaise D, Rubio MT, Guillaume T, Mohty M, Chevallier P,

Oncotarget. 2018 Nov 27;9(93):36603-36612

eGVHD App: a new tool to improve graft--host disease assessment.

Rubio MT

Haematologica. 2018 Oct;103(10):1583-1585

Outcomes of advanced Hodgkin lymphoma after umbilical cord blood transplantation: a Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party study.

Paviglianiti A, Maio KT, Rocha V, Gehlkopf E, Milpied N, Esquirol A, Chevallier P, Blaise D, Gac AC, Leblond V, Cahn JY, Abecasis M, Zuckerman T, Schouten H, Gurman G, Rubio MT, Beguin Y, Corral LL, Nagler A, Snowden JA, Koc Y, Mordini N, Bonifazi F, Volt F, Kenzey C, Robinson SP, Montoto S, Gluckman E, Ruggeri A

Biol. Blood Marrow Transplant.. 2018 Jul 18;:

Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chroni Malignancies Working Party of EBMT.

McLornan DP, Szydlo R, Robin M, van Biezen A, Koster L, Blok HJP, Van Lint MT, Finke J, Vitek A, Carlson K, Griskevicius L, Holler E, Itälä-Remes M, Schaap M, Socié G, Bay JO, Beguin Y, Bruno B, Cornelissen JJ, Gedde-Dahl T, Ljungman P, Rubio MT, Yakoub-Agha I, Klyuchnikov E, Olavarria E, Chalandon Y, Kröger N

Br. J. Haematol.. 2018 May 29;:

Unrelated cord blood transplantation in patients with acquired refractory aplastic anemia: a nationwide phase II study.

Peffault de Latour R, Chevret S, Jubert C, Sirvent A, Galambrun C, Ruggeri A, Gandemer V, Cornillon J, Rialland F, Dalle JH, Forcade E, Bruno B, Paillard C, Rorlich PS, Salmon A, Fürst S, Sicre de Fontbrune F, Rubio MT, Bay JO, Mohty M, Larghero J, Gluckman E, Socié G

Blood. 2018 May 14;:

HLA-DRB3/4/5 mismatches are associated with increased risk of acute GVHD in 10/10 matched unrelated donor hematopoietic cell transplantation.

Ducreux S, Dubois V, Amokrane K, Yakoub-Agha I, Labalette M, Michallet M, Rubio MT, Kennel A, Forcade E, Lafarge X, Bulabois CE, Masson D, Daguindau E, Devys A, Moalic V, Quelvennec E, Boudifa A, Picard C, Van Endert P, de Matteis M, Delbos F, Filloux M, Pedron B, Renac V, Hau F, Bonneau J, Parissiadis A, Fort M, Dormoy A, Maillard N, Jollet I, Chevallier P, Cesbron A, Bay JO, Quainon F, Garnier F, Socié G, Loiseau P, Porcher R, Peffault de Latour R, ,

Am. J. Hematol.. 2018 May 4;:

Epithelial chimerism in lung tissue after allogeneic hematopoietic stem cell transplantation.

Judet A, Copie-Bergman C, Zemoura L, Catherinot E, Martin N, Rivaud E, Nguyen S, Rubio MT, Belleguic C, Longchampt E, Tcherakian C, Couderc LJ, Salvator H,

Bone Marrow Transplant.. 2018 Apr;53(4):474-477

Hematopoietic stem cell transplantation for patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a retrospective study of 21 patients from SFGM-TC centers.

Vallet N, de Fontbrune FS, Loschi M, Desmier D, Villate A, Barraco F, Chevallier P, Terriou L, Yakoub-Agha I, Ruggeri A, Mohty M, Maillard N, Rohrlich PS, Ceballos P, Nguyen S, Poiré X, Guillerm G, Tabrizi R, Farhi J, Devillier R, Rubio MT, Socié G, de Latour RP,

Haematologica. 2018 Mar;103(3):e103-e105

Sequential Conditioning with Thiotepa in T Cell- Replete Hematopoietic Stem Cell Transplantation for the Treatment of Refractory Hematologic Malignancies: Comparison with Matched Related, Haplo-Mismatched, and Unrelated Donors.

Duléry R, Ménard AL, Chantepie S, El-Cheikh J, François S, Delage J, Giannotti F, Ruggeri A, Brissot E, Battipaglia G, Malard F, Belhocine R, Sestili S, Vekhoff A, Delhommeau F, Reman O, Legrand O, Labopin M, Rubio MT, Mohty M

Biol. Blood Marrow Transplant.. 2018 Jan 11;:

Human CD4- invariant NKT lymphocytes regulate graft versus host disease.

Coman T, Rossignol J, D'Aveni M, Fabiani B, Dussiot M, Rignault R, Babdor J, Bouillé M, Herbelin A, Coté F, Moura IC, Hermine O, Rubio MT

Oncoimmunology. 2018 ;7(11):e1470735

Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms-like tyrosine kinase 3-mutated acute myeloid leukemia.

Battipaglia G, Ruggeri A, Massoud R, El Cheikh J, Jestin M, Antar A, Ahmed SO, Rasheed W, Shaheen M, Belhocine R, Brissot E, Dulery R, Eder S, Giannotti F, Isnard F, Lapusan S, Rubio MT, Vekhoff A, Aljurf M, Legrand O, Mohty M, Bazarbachi A

Cancer. 2017 Aug 1;123(15):2867-2874

Scleral lenses for severe chronic GvHD-related keratoconjunctivitis sicca: a retrospective study by the SFGM-TC.

Magro L, Gauthier J, Richet M, Robin M, Nguyen S, Suarez F, Dalle JH, Fagot T, Huynh A, Rubio MT, Oumadely R, Vigouroux S, Milpied N, Delcampe A, Yakoub-Agha I

Bone Marrow Transplant.. 2017 Jun;52(6):878-882

Pre-transplant donor CD4 invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease.

Rubio MT, Bouillié M, Bouazza N, Coman T, Trebeden-Nègre H, Gomez A, Suarez F, Sibon D, Brignier A, Paubelle E, Nguyen-Khoc S, Cavazzana M, Lantz O, Mohty M, Urien S, Hermine O

Leukemia. 2017 Apr;31(4):903-912

Serum Gp96 is a chaperone of complement-C3 during graft-versus-host disease.

Seignez A, Joly AL, Chaumonnot K, Hazoumé A, Sanka M, Marcion G, Boudesco C, Hammann A, Seigneuric R, Jégo G, Ducoroy P, Delarue P, Senet P, Castilla-Llorente C, Solary E, Durey MA, Rubio MT, Hermine O, Kohli E, Garrido C

JCI Insight. 2017 Mar;2(6):e90531

Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working

Rubio MT, D'Aveni-Piney M, Labopin M, Hamladji RM, Sanz MA, Blaise D, Ozdogu H, Daguindeau E, Richard C, Santarone S, Irrera G, Yakoub-Agha I, Yeshurun M, Diez-Martin JL, Mohty M, Savani BN, Nagler A

J Hematol Oncol. 2017 01 24;10(1):31

Creation of an immunodeficient HLA-transgenic mouse (HUMAMICE) and functional validation of human immunity after transfer of HLA-matched human cells.

Zeng Y, Liu B, Rubio MT, Wang X, Ojcius DM, Tang R, Durrbach A, Ru Z, Zhou Y, Lone YC

PLoS ONE. 2017 ;12(4):e0173754

[Haploidentical hematopoietic stem cell transplantation: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)].

Nguyen S, Chalandon Y, Lemarie C, Simon S, Masson D, Dhedin N, Suarez F, Renaud B, Charbonnier A, Yafour N, François S, Duléry R, Blaise D, Yakoub-Agha I, Rubio MT

Bull Cancer. 2016 Nov;103(11S):S229-S242

The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years-a report from the EBMT acute leukemia working party.

Rubio MT, Savani BN, Labopin M, Polge E, Niederwieser D, Ganser A, Schwerdtfeger R, Ehninger G, Finke J, Renate A, Craddock C, Kröger N, Hallek M, Jindra P, Mohty M, Nagler A

J Hematol Oncol. 2016 08 3;9(1):65

Medullar toxicity after prolonged nitrous oxide exposure: an unexpected cause of bone marrow failure post allogeneic transplant.

Vozy A, Cohen M, Rubio MT, Rostaing-Rigattieri S, Mohty M, Mamez AC

Bone Marrow Transplant.. 2016 06;51(6):876-8

The impact of allogeneic-hematopoietic stem cell transplantation on patients' and close relatives' quality of life and relationships.

Poloméni A, Lapusan S, Bompoint C, Rubio MT, Mohty M

Eur J Oncol Nurs. 2016 Apr;21:248-56

Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT.

Rubio MT, Savani BN, Labopin M, Piemontese S, Polge E, Ciceri F, Bacigalupo A, Arcese W, Koc Y, Beelen D, Gülbas Z, Wu D, Santarone S, Tischer J, Afanasyev B, Schmid C, Giebel S, Mohty M, Nagler A

J Hematol Oncol. 2016 Mar 15;9:25

Depletion of CD11c⁺ cells in the CD11c.DTR model drives expansion of unique CD64⁺ Ly6C⁺ monocytes that are poised to release TNF-α.

Sivakumaran S, Henderson S, Ward S, Sousa PS, Manzo T, Zhang L, Conlan T, Means TK, D'Aveni M, Hermine O, Rubio MT, Chakraverty R, Bennett CL

Eur. J. Immunol.. 2016 Jan;46(1):192-203

Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipients.

Ruggeri A, Roth-Guepin G, Battipaglia G, Mamez AC, Malard F, Gomez A, Brissot E, Belhocine R, Vekhoff A, Lapusan S, Isnard F, Legrand O, Gozlan J, Boutolleau D, Ledraa T, Labopin M, Rubio MT, Mohty M

Transpl Infect Dis. 2015 Dec;17(6):822-30

Safety and feasibility of romiplostim treatment for patients with persistent thrombocytopenia after allogeneic stem cell transplantation.

Battipaglia G, Ruggeri A, Brissot E, Mamez AC, Malard F, Belhocine R, Vekhoff A, Giannotti F, Ledraa T, Labopin M, Rubio MT, Mohty M

Bone Marrow Transplant.. 2015 Dec;50(12):1574-7

Inflammatory bowel disease after allogeneic stem cell transplantation.

Boussen I, Sokol H, Aractingi S, Georges O, Hoyeau-Idrissi N, Hugot JP, Mohty M, Rubio MT

Bone Marrow Transplant.. 2015 Oct;50(10):1365-6

HLA-matched allogeneic stem cell transplantation improves outcome of higher risk myelodysplastic syndrome A prospective study on behalf of SFGM-TC and GFM.

Robin M, Porcher R, Adès L, Raffoux E, Michallet M, François S, Cahn JY, Delmer A, Wattel E, Vigouroux S, Bay JO, Cornillon J, Huynh A, Nguyen S, Rubio MT, Vincent L, Maillard N, Charbonnier A, de Latour RP, Reman O, Dombret H, Fenaux P, Socié G

Leukemia. 2015 Jul;29(7):1496-501

The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Rubio MT, Labopin M, Blaise D, Socié G, Contreras RR, Chevallier P, Sanz MA, Vigouroux S, Huynh A, Shimoni A, Bulabois CE, Caminos N, López-Corral L, Nagler A, Mohty M

Haematologica. 2015 May;100(5):683-9

G-CSF mobilizes CD34+ regulatory monocytes that inhibit graft-versus-host disease.

D'Aveni M, Rossignol J, Coman T, Sivakumaran S, Henderson S, Manzo T, Santos e Sousa P, Bruneau J, Fouquet G, Zavala F, Alegria-Prévot O, Garfa-Traoré M, Suarez F, Trebeden-Nègre H, Mohty M, Bennett CL, Chakraverty R, Hermine O, Rubio MT

Sci Transl Med. 2015 Apr 1;7(281):281ra42

Report of disseminated Mycobacterium haemophilum infection after double cord blood allo-SCT.

Brissot E, Gomez A, Aline-Fardin A, Lalande V, Lapusan S, Isnard F, Legrand O, Meynard JL, Rubio MT, Mohty M

Bone Marrow Transplant.. 2014 Oct;49(10):1347-8

Upfront allogeneic stem cell transplantation after reduced-intensity/nonmyeloablative conditioning for patients with myelodysplastic syndrome: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

Damaj G, Mohty M, Robin M, Michallet M, Chevallier P, Beguin Y, Nguyen S, Bories P, Blaise D, Maillard N, Rubio MT, Fegueux N, Cornillon J, Clavert A, Huynh A, Adès L, Thiébaut-Bertrand A, Hermine O, Vigouroux S, Fenaux P, Duhamel A, Yakoub-Agha I

Biol. Blood Marrow Transplant.. 2014 Sep;20(9):1349-55

Fiche personne Projets Publications

Retrouvez aussi

Personnes

Equipes

Plateformes

Unités de recherche, établissements

Projets de recherche

Publications scientifiques